- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Stroke
Clotting Risk Persists Nearly a Year Following COVID-19 Infection
September 23, 2022
A new study encompassing data from more than 48,000,000 patients provides insight into the risk of major arterial and cerebrovascular diseases up to 49 weeks following initial COVID-19 diagnosis.
Optimized Cardiovascular Health Could Offset Genetic Stroke Risk by 30-40%
July 21, 2022
An analysis of data from the ARIC study provides insight into the impact of genetic risk scores on lifetime risk of stroke and how optimal cardiovascular health might influence this risk.
Proximal DVT Associated with Worse Prognosis, Outcomes than Isolated Distal DVT
July 18, 2022
An analysis of data from more than 30k patients with DVT from the RIETE registry is providing clinicians with new insight into the difference in presentation and outcomes among patients with isolated distal DVT and proximal DVT.
Most Stroke Patients Have Undiagnosed Major Risk Factors
June 28, 2022
An analysis of data from a single center in Switzerland from a 15-year period details the prevalence of undiagnosed major risk factors among patients admitted with acute ischemic stroke, suggesting 67.7% present with at least 1 undiagnosed risk factor.
Studies Detail Thrombosis Risks Associated with Different COVID-19 Vaccines
June 27, 2022
Dr. Gregory Weiss provides perspective on a recent study detailing the risks of thrombosis observed with different COVID-19 vaccines among patients from a group of countries in Europe.
Cardiology Month in Review: May 2022
May 28, 2022
Our cardiology month in review spotlights the most popular content from the past month. This month's top articles include news from DELIVER, new guidelines for ICH and PFO, and a juxtaposition of international heart failure guidelines.
AUGUSTUS Results Consistent, Regardless of Stroke History, Study Finds
May 25, 2022
A post hoc analysis of the AUGUSTUS trial provides an overview of the effects of various antithrombotic regimens after ACS or PCI in patients with AFib and a history of stroke, TIA, or thromboembolism.
Prostate Cancer Could Increase Risk of DVT, Pulmonary Embolism by Nearly 50%
May 24, 2022
An analysis of national data from Sweden suggests men with prostate cancer were at a 48% greater risk of deep vein thrombosis and a 47% greater risk of pulmonary embolism compared to their counterparts without prostate cancer.
American Heart, Stroke Associations Release Updated Guidance for Intracerebral Hemorrhage
May 17, 2022
Published on May 17, the 2022 AHA/ASA guidelines for the management of intracerebral hemorrhage were created with the intent of replacing 2015 guidance with updated evidence-based recommendations.
Black Patients with AFib 25% Less Likely to Receive Oral Anticoagulant Therapy at Discharge
April 29, 2022
A study from HRS 2022 suggests Black patients with AFib were 25% less likely to be on oral anticoagulants at hospital discharge compared to their White counterparts those discharged 18% less likely to receive DOACs than their White counterparts.